December 19, 2014 5:03 PM ET

Biotechnology

Company Overview of StemPath, Inc.

Company Overview

StemPath, Inc. develops therapeutic solutions for modulating body’s natural regenerative capacity and endogenously replacing damaged tissues with new tissues by intervention with small molecule and biological drugs. It develops peptide-based pharmaceuticals to stimulate heart and skeletal muscle regeneration. It offers cardiac and skeletal muscle myopathies. The company was founded in 2002 and is based in Ottawa, Canada.

501 Smyth Road

Box 511

Ottawa, ON K1H 8L6

Canada

Founded in 2002

Phone:

613-737-8899

Fax:

613-737-8399

Key Executives for StemPath, Inc.

Co-Founder
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Resolution Pharmaceuticals Inc. Americas
IatroQuest Corporation Americas
Planteck Biotechnologies Inc. Americas
Asmacure Ltée Americas
Receptor Therapeutics Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact StemPath, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.